Fuji Pharma Cash Flow Statement

Financials in millions JPY. Fiscal year is October - September.

Millions JPY. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Income	4,000	8,276	4,399	3,723	3,371
Depreciation & Amortization	3,965	3,680	3,023	2,745	2,106
Loss (Gain) From Sale of Assets	394	-	4	1	33
Loss (Gain) From Sale of Investments	-	-3,118	-	-	-153
Other Operating Activities	-2,193	-1,027	-941	-1,504	-915
Change in Accounts Receivable	525	-1,997	-3,705	-549	-174
Change in Inventory	-3,078	1,552	-3,395	-3,618	-1,340
Change in Accounts Payable	356	-1,640	-652	447	2,038
Change in Other Net Operating Assets	1,832	-1,575	3,184	-1,903	1,027
Operating Cash Flow	5,801	4,151	1,917	-658	5,993
Operating Cash Flow Growth	39.75%	116.54%	-	-	3.86%
Capital Expenditures	-1,981	-2,778	-3,327	-5,097	-3,789
Sale of Property, Plant & Equipment	2	2	10	1,383	1,673
Sale (Purchase) of Intangibles	-1,873	-1,594	-570	-7,326	-107
Investment in Securities	-	5,356	-	-	189
Other Investing Activities	-367	-2,644	-1,353	-231	-311
Investing Cash Flow	-4,219	-1,658	-5,240	-11,271	-2,345
Short-Term Debt Issued	-	4,000	3,000	1,300	6,000
Long-Term Debt Issued	9,987	-	2,985	7,300	1,000
Total Debt Issued	9,987	4,000	5,985	8,600	7,000
Long-Term Debt Repaid	-7,749	-5,210	-2,740	-2,140	-1,756
Total Debt Repaid	-7,749	-5,210	-2,740	-2,140	-1,756
Net Debt Issued (Repaid)	2,238	-1,210	3,245	6,460	5,244
Issuance of Common Stock	210	55	-	-	11
Repurchase of Common Stock	-	-	-	-	-9,405
Common Dividends Paid	-1,036	-972	-899	-729	-807
Other Financing Activities	-458	1,692	-431	-637	-478
Financing Cash Flow	954	-435	1,915	5,094	-5,435
Foreign Exchange Rate Adjustments	123	202	185	183	-55
Miscellaneous Cash Flow Adjustments	1	-	2	-1	-
Net Cash Flow	2,660	2,260	-1,221	-6,653	-1,842
Free Cash Flow	3,820	1,373	-1,410	-5,755	2,204
Free Cash Flow Growth	178.22%	-	-	-	-36.08%
Free Cash Flow Margin	7.39%	2.98%	-3.45%	-16.25%	6.48%
Free Cash Flow Per Share	156.54	56.48	-58.02	-236.90	82.03
Cash Interest Paid	327	194	104	82	59
Cash Income Tax Paid	2,197	1,026	946	1,498	911
Levered Free Cash Flow	535.5	599.13	-4,258	-11,724	1,392
Unlevered Free Cash Flow	741.75	721.63	-4,182	-11,676	1,425
Change in Working Capital	-365	-3,660	-4,568	-5,623	1,551

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.